832114-05-3 Usage
General Description
3-((N-BOC-AMINO)METHYL)PHENYLBORONIC ACID is a chemical compound with the molecular formula C14H20BNO4. It is a boronic acid derivative containing a BOC-protected amino group attached to a phenyl ring. 3-((N-BOC-AMINO)METHYL)PHENYLBORONIC ACID is commonly used as a reagent in organic synthesis, particularly in the preparation of pharmaceuticals and agrochemicals. The BOC group is often used to temporarily protect the amine functionality, allowing for selective reactions to occur at other sites in the molecule. Additionally, the boronic acid functionality in this compound allows for the formation of stable complexes with diols, making it useful in the development of new materials and in catalytic processes. Overall, 3-((N-BOC-AMINO)METHYL)PHENYLBORONIC ACID is an important building block for the synthesis of various organic molecules with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 832114-05-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,2,1,1 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 832114-05:
(8*8)+(7*3)+(6*2)+(5*1)+(4*1)+(3*4)+(2*0)+(1*5)=123
123 % 10 = 3
So 832114-05-3 is a valid CAS Registry Number.
InChI:InChI=1/C18H28BNO4/c1-16(2,3)22-15(21)20-12-13-9-8-10-14(11-13)19-23-17(4,5)18(6,7)24-19/h8-11H,12H2,1-7H3,(H,20,21)
832114-05-3Relevant articles and documents
Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy
Zhang, Zhuqing,Guo, Zuhao,Xu, Xiaowei,Cao, Danyan,Yang, Hong,Li, Yanlian,Shi, Qiongyu,Du, Zhiyan,Guo, Xiaobin,Wang, Xin,Chen, Danqi,Zhang, Ying,Chen, Lin,Zhou, Kaixin,Li, Jian,Geng, Meiyu,Huang, Xun,Xiong, Bing
, p. 16650 - 16674 (2021/12/02)
CARM1 is a protein arginine methyltransferase and acts as a transcriptional coactivator regulating multiple biological processes. Aberrant expression of CARM1 has been related to the progression of multiple types of cancers, and therefore CARM1 was consid
COMPOUNDS AND USES THEREOF
-
Page/Page column 231; 232, (2021/08/06)
The present disclosure features compounds and methods useful for the treatment of BAF complex-related disorders.
COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF
-
Paragraph 0137; 0138; 0140, (2020/05/30)
Disclosed are a class of coumarin-like cyclic compounds as MEK inhibitors and pharmaceutical compositions comprising the compounds, and the use of same in the preparation of a drug for treating MEK-related diseases. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof or tautomers thereof.
